Capecitabine
Showing 2051 - 2075 of 2,332
Breast Cancer Trial in United States (Bevacizumab, Docetaxel, CPT-11)
Metastatic Breast Cancer Trial in Goyang-si (Irinotecan, Capecitabine)
Unknown status
- Metastatic Breast Cancer
- Irinotecan, Capecitabine
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Jul 17, 2012
Solid Tumor Trial in Memphis (Tesetaxel plus capecitabine)
Unknown status
- Solid Tumor
- Tesetaxel plus capecitabine
-
Memphis, TennesseeThe West Clinic
Jul 23, 2012
Cancer of the Gallbladder, Cancer of the Biliary Tract Trial in Houston (Capecitabine, Oxaliplatin)
Completed
- Cancer of the Gallbladder
- Cancer of the Biliary Tract
- Capecitabine
- Oxaliplatin
-
Houston, TexasU.T. M.D. Anderson Cancer Center
Jul 27, 2012
Advanced Solid Tumors Trial in Indianapolis, Las Vegas, Vancouver (indibulin, capecitabine)
Unknown status
- Advanced Solid Tumors
- indibulin
- capecitabine
-
Indianapolis, Indiana
- +2 more
Jul 18, 2012
Pancreatic Cancer Trial in Houston (Bevacizumab, Capecitabine, Radiotherapy)
Completed
- Pancreatic Cancer
- Bevacizumab
- +2 more
-
Houston, TexasUniversity of Texas MDAnderson Cancer Center
Jul 31, 2012
Breast Tumors, Leptomeningeal Metastasis, Brain Metastases Trial in Taipei City (Bevacizumab, etoposide, cisplatin, Intrathecal
Completed
- Breast Neoplasms
- +2 more
- Bevacizumab, etoposide, cisplatin
- Intrathecal methotrexate
-
Taipei City, TaiwanDepartment of Oncology, National Taiwan University Hospital
Oct 15, 2013
Colonic Tumors Trial in Guangzhou (cytokine-induced killer cells)
Unknown status
- Colonic Neoplasms
- cytokine-induced killer cells
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
Aug 27, 2013
Dose Adaptation of Capecitabine Using Mobile Phone Toxicity
Completed
- Metastatic Colorectal Cancer
- Metastatic Breast Cancer
-
Oxford, United KingdomOxford Cancer Centre, Churchill Hospital
Jul 24, 2012
Anal, Colon, and Rectal Cancers, Colorectal Tumors, Colon/Rectal Cancer Trial in Stanford (Vandetanib, Capecitabine,
Completed
- Anal, Colon, and Rectal Cancers
- +2 more
- Vandetanib
- +3 more
-
Stanford, CaliforniaStanford University School of Medicine
Jul 12, 2012
Metastatic Breast Cancer Trial (Bevacizumab, Placebo, Standard chemo)
Rectal Cancer Trial in Houston (Avastin (Bevacizumab, RHUMAB VEGF), Capecitabine, Radiation Therapy)
Completed
- Rectal Cancer
- Avastin (Bevacizumab, RHUMAB VEGF)
- +2 more
-
Houston, TexasUT M. D. Anderson Cancer Center
Jul 31, 2012
Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in
Completed
- Rectal Cancer
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Aug 21, 2012
Colorectal Cancer Trial in United States (capecitabine)
Completed
- Colorectal Cancer
- capecitabine
-
Mobile, Alabama
- +89 more
Jan 2, 2013
Gastric Adenocarcinoma Trial (nanoparticle Albumin-Bound paclitaxel)
Unknown status
- Gastric Adenocarcinoma
- nanoparticle Albumin-Bound paclitaxel
- (no location specified)
Jul 13, 2012
Colorectal Cancer, Metastatic Cancer Trial in United Kingdom (biological, drug, other, procedure)
Unknown status
- Colorectal Cancer
- Metastatic Cancer
- cetuximab
- +8 more
-
Basildon, England, United Kingdom
- +21 more
Jan 22, 2013
Breast Cancer Trial in Worldwide (capecitabine, vinorelbine tartrate)
Terminated
- Breast Cancer
- capecitabine
- vinorelbine tartrate
-
Antwerp, Belgium
- +11 more
Jul 17, 2012
Rectal Cancer, Gastric Cancer, Bone Marrow Toxicity Trial in Beijing (Bone Marrow-sparing Intensity-Modulated Radiotherapy)
Unknown status
- Rectal Cancer
- +3 more
- Bone Marrow-sparing Intensity-Modulated Radiotherapy
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
May 28, 2013
Esophageal Cancer Trial in United Kingdom (biological, drug, radiation)
Unknown status
- Esophageal Cancer
- cetuximab
- +3 more
-
Birmingham, England, United Kingdom
- +54 more
Dec 17, 2012
Colorectal Cancer Trial in Worldwide (FOLFIRI regimen, capecitabine, celecoxib)
Completed
- Colorectal Cancer
- FOLFIRI regimen
- +5 more
-
Antwerp, Belgium
- +27 more
Sep 20, 2012
Breast Cancer Trial in Geneva (capecitabine, cyclophosphamide, epirubicin HCl)
Completed
- Breast Cancer
- capecitabine
- +2 more
-
Geneva, SwitzerlandHopital Cantonal Universitaire de Geneva
Jul 17, 2012
Infiltrating Duct and Lobular Carcinoma In Situ, Invasive Lobular Breast Carcinoma, Inflammatory Breast Carcinoma Trial in San
Unknown status
- Infiltrating Duct and Lobular Carcinoma In Situ
- +2 more
- Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab
-
San Juan, Puerto RicoHospital Auxilio Mutuo Cancer Center
Jul 12, 2012